Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Meigs: Association of Oxidative Stress, Insulin Resistance, and Diabetes Risk Phenotypes. (0.13 sec) 

Association of Oxidative Stress, Insulin Resistance, and Diabetes Risk Phenotypes


JB Meigs, MG Larson, CS Fox, JF Keaney, RS … - Diabetes Care, 2007 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS—We used cross-sectional data from 2,002
nondiabetic subjects of the community-based Framingham Offspring Study. We
measured insulin resistance with the homeostasis model and defined ...
Cited by 28 - Related articles - BL Direct - All 5 versions

Association of Oxidative Stress, Insulin Resistance, and Diabetes Risk Phenotypes: The …


MD Keaney Jr, RS Vasan, EJBMD ScM, JBM … - Am Diabetes Assoc
1) General Medicine Division and Department of Medicine, Massachusetts General
Hospital and Harvard Medical School, Boston, MA. 2) Department of Mathematics
and Statistics, Boston University, Boston, and the National Heart, Lung, ...
Related articles

Fluvastatin reduces oxidative damage in human vascular endothelial cells by upregulating …


SZ Xu, W Zhong, NM Watson, E Dickerson, JD … - Journal of Thrombosis and Haemostasis, 2008 - interscience.wiley.com
Background: 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins)
have been widely used in clinical practise and their efficacy in reducing
cardiovascular risk has been well described. Objectives: To investigate the ...
Cited by 5 - Related articles - BL Direct - All 3 versions

The underlying mechanisms for development of hypertension in the metabolic syndrome


H Yanai, Y Tomono, K Ito, N Furutani, H … - Nutrition Journal, 2008 - nutritionj.com
The metabolic syndrome is characterized by the simultaneous occurrence of
metabolic abnormalities including obesity, glucose intolerance, dyslipidemia,
and hypertension, that result in a marked increase in cardiovascular ...
Cited by 16 - Related articles - Cached - All 10 versions

Urinary F2-isoprostanes are not associated with increased risk of type 2 diabetes.


D Il'yasova, JD Morrow, LE Wagenknecht - Obesity research, 2005 - ncbi.nlm.nih.gov
OBJECTIVE: Free radicals have been implicated in the etiology of type 2
diabetes. Cross-sectional studies have demonstrated associations between
oxidative damage and type 2 diabetes. However, no prospective data on this ...
Cited by 11 - Related articles - BL Direct - All 2 versions

Роль и место тиоктовой кислоты в комплексной терапии сахарного диабета


КВ Антонова, ЛВ Недосугова - Трудный пациент, 2008 - t-pacient.ru
При диабетической нейропатии происходит
поражение сенсорных нервных волокон
разного диаметра. Как правило, в первую ...
Cited by 1 - Related articles - Cached

Mammalian iron metabolism


LG Valerio Jr - Toxicology Mechanisms and Methods, 2007 - informahealthcare.com
Iron is an essential transition metal for mammalian cellular and tissue
viability. It is critical to supplying oxygen through heme, the mitochondrial
respiratory chain, and enzymes such as ribonucleotide reductase. Mammalian ...
Cited by 2 - Related articles - BL Direct - All 7 versions

[CITATION] New multidentate ligands. 6. chelating tendencies of N, N'-di (2-hydroxybenzyl) …


F L'Eplattenier, I Murase, AE Martell - JACS, 1967
Cited by 2 - Related articles

Spatial correlation of trace elements with morphological features of atherosclerotic plaques


RB Roijers, RK Dutta, PHA Mutsaers, MJJ … - Nuclear Inst. and Methods in Physics Research, B, 2005 - Elsevier
Atherosclerosis is a progressive inflammatory disease characterised by
accumulation of lipid material originating from low-density lipoproteins (LDL)
in the intimal layer of larger arteries. Atherosclerotic plaques consist of ...
Cited by 2 - Related articles - All 3 versions

Structure-activity relationships of novel iron chelators for the treatment of iron overload …


DS Kalinowski, PC Sharpe, PV Bernhardt, DR … - Journal of medicinal chemistry, 2008 - ncbi.nlm.nih.gov
The design of novel Fe chelators with high Fe mobilization efficacy and low
toxicity remains an important priority for the treatment of Fe overload disease.
We have designed and synthesized the novel methyl pyrazinylketone ...
Cited by 2 - Related articles - All 4 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google